Pharmaceutical

NICE supports Theramex’s Eladynos for post-menopause osteoporosis

Eladynos is a synthetic peptide analogue of parathyroid hormone-related protein (PTHrP) used to increase bone density.

Aug 11, 2024 - 04:00
NICE supports Theramex’s Eladynos for post-menopause osteoporosis
Eladynos is a synthetic peptide analogue of parathyroid hormone-related protein (PTHrP) used to increase bone density.
Read the original article

Tags:

Previous Article

MSD sets sights on bispecific antibody market with Curon acqusition

Next Article

Eli Lilly boosts sales forecast by $3bn as diabetes and weight loss drugs propel...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Searchlight licenses Mithra’s menopause drug Donesta for Canadian market

Searchlight licenses Mithra’s menopause drug Donesta fo...

Jul 31, 2023

Verona Pharma’s ensifentrine inches closer to approval decision in COPD

Verona Pharma’s ensifentrine inches closer to approval ...

Sep 11, 2023

Taiho exercises option for Arcus Biosciences’ quemliclustat in Asia

Taiho exercises option for Arcus Biosciences’ quemliclu...

Jul 10, 2024